T45.69
Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T45.69 refers to cases of poisoning, adverse effects, or underdosing related to drugs that influence fibrinolysis, a process important for breaking down blood clots. Fibrinolytic agents are medications used in medical settings to dissolve clots that can cause serious conditions like strokes or heart attacks. While these drugs are lifesaving, they can also lead to complications if improperly used, resulting in bleeding or other adverse reactions. This guide aims to provide a clear understanding of poisoning related to these drugs, including causes, symptoms, diagnosis, and general treatment considerations.
Causes & Symptoms
Clinical Causes: Accidental overdose of fibrinolytic drugs. Intentional misuse or abuse of fibrinolytic medications. Incorrect administration or dosing errors during treatment. Use of fibrinolytic drugs without proper medical supervision. Drug interactions that enhance the effect of fibrinolytics or increase bleeding risk. Inadequate monitoring of patient response during therapy.
Key Symptoms: Unusual or excessive bleeding, such as nosebleeds or bleeding gums. Blood in urine or stools. Bruising easily or unexplained large bruises. Heavy or prolonged bleeding after injuries or medical procedures. Signs of internal bleeding, such as abdominal pain or swelling, dizziness, or weakness. Allergic reactions, including rash, itching, or swelling.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves reviewing the patient's medical history, medication usage, and clinical presentation. Blood tests, such as coagulation profiles, help assess bleeding risks and confirm if there is an adverse effect related to fibrinolytic drugs. Healthcare providers may also evaluate the timing of medication administration and correlate it with symptoms to determine if poisoning or adverse effects have occurred.
Treatment Protocols: Discontinuing or adjusting the dose of the fibrinolytic medication under medical supervision. Implementing supportive care, such as fluid replacement and blood transfusions if significant bleeding occurs. Use of reversal agents or medications that promote clot formation, if applicable and available. Close monitoring of vital signs and blood clotting parameters. Treating any underlying conditions that may have contributed to the adverse reaction.
Clinical Advice & FAQs
Billing Guidance
Is T45.69 a billable ICD-10 code?
Yes, T45.69 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.69?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference